Skip to main content

ADVERTISEMENT

head-to-head trial

Research in Review
12/07/2015
JCP Editors
A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A phase 3 head-to-head trial comparing the effectiveness of Kyprolis (carfilzomib) in combination with dexamethasone has shown better outcomes in patients with multiple myeloma than the current standard of care,...
A...
12/07/2015
Journal of Clinical Pathways